Missouri · 2026 Regular Session · Concurrent Resolution
SCR 19: Expresses support for TrumpRx and the GENEROUS Model
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SCR 19 is a concurrent resolution introduced in the Missouri Senate on February 5, 2026. According to its official title, it concerns: Expresses support for TrumpRx and the GENEROUS Model. Primary sponsor: Nick Schroer (Republican). Most recent recorded action (February 9, 2026): Referred S Rules, Joint Rules, Resolutions and Ethics Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
SCR 19 - This concurrent resolution urges the U.S. Department of Health and Human Services to prevent discriminatory insurance practices and require insurance plans and pharmacy benefit managers to apply all patient-paid prescription drug expenditures, including those obtained through the new TrumpRx platform, toward patients' cost-sharing requirements. Additionally, this concurrent resolution urges the Department of Social Services to assess the new GENEROUS Model for MO HealthNet participation. SARAH HASKINS
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Nick Schroer | Primary sponsor | Republican | Senate | 2 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Referred S Rules, Joint Rules, Resolutions and Ethics Committee
- S Offered